Ansun BioPharma

About:

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.

Website: http://www.ansunbiopharma.com/

Twitter/X: ansunbiopharma

Top Investors: Lilly Asia Ventures, Matrix Partners China, Korea Investment Partners, 3E Bioventures, LYFE Capital

Description:

Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virus is difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus. The company was founded in 2003 and is headquartered in San Diego, California.